About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Articles

Combined Antithrombotic Regimens and the OPTIMA-AF trial

Published:

25 February 2026

Citation:

European Cardiology Review 2026;21:e10.

Revascularisation in Patients with Cancer

Published:

21 January 2026

Citation:

European Cardiology Review 2026;21:e02.

Innovation and Development of PHV TAVR

Published:

30 October 2025

Citation:

European Cardiology Review 2025;20:e29.

Left Main Disease: The Last Frontier for Medical Therapy in Stable CAD?

Published:

15 September 2025

Citation:

European Cardiology Review 2025;20:e24.